New Online Course Provides Information on Ethical Issues and Governance Approaches for Emerging Technologies
7 July 2020 by CITI Program

Since the onset and spread of COVID-19, many communities, businesses and individuals have relied on some of the latest technologies. From telemedicine to teleconferencing to…

CIP Exam Preparation and Recertification Using CITI Program Content
30 June 2020 by CITI Program

Study Help for the CIP Exam As the application deadline for the Fall 2020 CIP examination approaches (14 August for the exam window of 7…

New HHS Fact Sheet: COVID-19’s Impact on Minorities
10 June 2020 by CITI Program

The HHS has released HHS Initiatives to Address the Disparate Impact of COVID-19 on African Americans and Other Racial and Ethnic Minorities. It covers the…

FDA Issues New COVID-19 Guidance for IRBs and Clinical Investigators
4 June 2020 by CITI Program

In order to support response efforts to this pandemic, the FDA has issued guidance to provide non-binding recommendations regarding the key factors and procedures IRBs…

Technology, Ethics, and COVID-19
3 June 2020 by CITI Program

Read AI, Robots, and Ethics in the Age of COVID-19 published by MIT’s “Sloan Management Review” for an expert’s perspective on the impact of robots…

CITI Program Contributor Kelly Willenberg Has a New Research Blog
2 June 2020 by CITI Program

Kelly Willenberg, DBA, RN, CCRP, CHRC, CHC is one of CITI Program’s expert contributors in clinical trial billing. As a respected expert in the research…

COVID-19 Trial Shows Remdesivir is Superior to Standard Treatment
26 May 2020 by CITI Program

According to the authors of a recently published article in the New England Journal of Medicine, findings from the Adaptive COVID-19 Treatment Trial, support remdesivir…

CTTI Webinar – Engaging Racial and Ethnic Minority Patient Populations in COVID-19 Clinical Trials
16 June 2020 by CITI Program

At 12 PM ET on Thursday, June 18, CTTI will host Engaging Racial and Ethnic Minority Patient Populations in COVID-19 Clinical Trials. The webinar will…

Recovery From Advanced COVID-19 Accelerated by Remdesivir in NIH Clinical Trial
30 April 2020 by CITI Program

In an NIH clinical trial involving 1063 patients with advanced COVID-19, preliminary results indicate that those who received broad-spectrum antiviral treatment Remdesivir recovered 31% faster…

Researchers Race Toward a COVID-19 Vaccine at Breakneck Speed
29 April 2020 by CITI Program

In recent weeks biotech and clinical research communities have pivoted resources toward developing vaccines against SARS-CoV-2. Teams around the world are researching various methods of…

CITI Program Author Charles Hennekens Publishes Several Articles on COVID-19 and Public Health
28 April 2020 by CITI Program

Charles Hennekens, MD, DrPH is one of the expert authors of CITI Program’s Essentials of Public Health Research course. As a respected expert on public…

New Questions and Answers Added to the FDA Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency
23 April 2020 by CITI Program

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency was released in March for industry, investigators, and institutional review…